The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
Open accessAbstract
Brain sigma-type receptors are thought to mediate hallucinogenic effects of certain benzomorphan opiates in humans. The biochemical characterization of sigma receptors has been difficult because of the lack of potent and selective ligands. We report here the synthesis and characterization of a tritiated, symmetrically substituted guanidine derivative, 1,3-di(2-[5-3H]tolyl)guanidine ([3H]Tol2Gdn), that binds with high affinity to a single population of binding sites in guinea pig brain membrane preparations. The [3H]Tol2Gdn binding site displays stereoselectivity for dextrorotatory optical isomers of benzomorphan opiates known to have sigma-type behavioral effects. Furthermore, the [3H]Tol2Gdn binding site has a high affinity for haloperidol and for phenothiazine antipsychotics, which have antihallucinatory properties in humans. The drug-selectivity profile of [3H]Tol2Gdn binding closely correlates with the drug-selectivity profile of tritiated (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [+)-[3H]3-PPP) binding to guinea pig brain membrane receptors. (+)-[3H]3-PPP has been proposed to be a selective sigma-receptor ligand [Largent, B. L., Gundlach, A. L. & Snyder, S. H. (1984) Proc. Natl. Acad. Sci. USA 82, 4983-4987]. Receptor autoradiography using [3H]Tol2Gdn on slide-mounted rat and guinea pig brain sections reveals a heterogeneous distribution pattern of enriched binding in limbic and sensorimotor structures of the brain. These results indicate that [3H]Tol2Gdn is a selective ligand for the sigma-site. Availability of this sigma-receptor probe should greatly facilitate the physiological, biochemical, and pharmacological characterization of sigma receptors in brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Seeman, P. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,892
A practical computer-based approach to the analysis of radioligand binding experiments
McPherson, G. A. (1983) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(83)90031-4 · Cited by 829
CLASSIFICATION OF OPIOID RECEPTORS
PATERSON, S. J., ROBSON, L. E., & KOSTERLITZ, H. W. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071787 · Cited by 790
Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography.
Goodman, R. R., Snyder, S. H., Kuhar, M. J., & Young, W. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.6239 · Cited by 466
Herkenham, M., & Pert, C. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-08-01129.1982 · Cited by 465
Su, T. P. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33330-6 · Cited by 436
Tam, S. W., & Cook, L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5618 · Cited by 349
Largent, B. L., Gundlach, A. L., & Snyder, S. H. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24925-4 · Cited by 347
3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors
Hjorth, S., Carlsson, A., Wikström, H., Lindberg, P., Sanchez, D., Hacksell, U., Arvidsson, L.-E., Svensson, U., & Nilsson, J. L. G. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90448-3 · Cited by 229
Naloxone-inaccessible sigma receptor in rat central nervous system.
Tam, S. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.21.6703 · Cited by 218
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP
Hjorth, S., Carlsson, A., Clark, D., Svensson, K., Wikstr�m, H., Sanchez, D., Lindberg, P., Hacksell, U., Arvidsson, L. E., Johansson, A., et al. (1983) · Psychopharmacology · doi:10.1007/bf00428999 · Cited by 199
Largent, B. L., Gundlach, A. L., & Snyder, S. H. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4983 · Cited by 196
Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog
Bruce Vaupel, D. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90297-2 · Cited by 193
Iwamoto, E. T. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32553-x · Cited by 173
Tam, S. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90536-9 · Cited by 172
Autoradiographic localization of μ- and δ-opiate receptors in the forebrain of the rat
McLean, S., Rothman, R. B., & Herkenham, M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90285-4 · Cited by 170
Self-citationBrady, K. T., Balster, R. L., & May, E. L. (1982) · Science · doi:10.1126/science.6274022 · Cited by 165
Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites.
Zukin, R. S., & Zukin, S. R. (1981) · PubMed · Cited by 151
Haertzen, C. A. (1970) · Psychopharmacology · doi:10.1007/bf00402763 · Cited by 126
Phencyclidine and σ opiate receptors in brain: Biochemical and autoradiographical differentiation
Gundlach, A. L., Largent, B. L., & Snyder, S. H. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90100-1 · Cited by 123
Goodman, R. R., & Snyder, S. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5703 · Cited by 107
Sircar, R., Nichtenhauser, R., Ieni, J. R., & Zukin, S. R. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25003-0 · Cited by 103
Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers
Arnt, J., B�ges�, K. P., Christensen, A. V., Hyttel, J., Larsen, J. ‐., & Svendsen, O. (1983) · Psychopharmacology · doi:10.1007/bf00427262 · Cited by 87
Quantitative localization of [3H]TCP binding in rat brain by light microscopy autoradiography
Sircar, R., & Zukin, S. R. (1985) · Brain Research · doi:10.1016/0006-8993(85)91198-9 · Cited by 53
Khazan, N., Young, G. A., El-Fakany, E. E., Hong, O., & Calligaro, D. O. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90015-7 · Cited by 48
III. Simple tests that differentiate prototype agonists at opiate receptors
Cowan, A. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90310-6 · Cited by 36
Cited by
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T.-P., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 546
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Su, T.-P., Hayashi, T., Maurice, T., Buch, S., & Ruoho, A. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.007 · Cited by 466
[3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes
Wong, E. H. F., Knight, A. R., & Woodruff, G. N. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13260.x · Cited by 454
Monnet, F. P., Mahé, V, Robel, P., & Baulieu, E. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3774 · Cited by 429
Hellewell, S. B., Bruce, A., Feinstein, G., Orringer, J., Williams, W., & Bowen, W. D. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90115-5 · Cited by 390
Metadata
- Authors
- Weber, E., Sonders, M., Quarum, M., McLean, S., Pou, S., & Keana, J. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-11
- Volume
- 83
- Issue
- 22
- Pages
- 8784-8788
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2061633232
- Cited by
- 376
- References
- 28
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.